-+ 0.00%
-+ 0.00%
-+ 0.00%

DongKook Pharma calls extraordinary shareholders meeting on proposed name change to DK Centellian

PUBT·10/12/2026 01:14:01
DongKook Pharma calls extraordinary shareholders meeting on proposed name change to DK Centellian
  • DongKook Pharmaceutical will hold an extraordinary shareholders’ meeting on Nov. 27, 2026.
  • Shareholders will vote on amending the articles to change the company name to DK Centellian.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DongKook Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261012900140), on October 12, 2026, and is solely responsible for the information contained therein.